Tirzepatide compounding outcome: Restricted with shortage carve-out

Voided · refunded

Volume: 427 SP
Holders: 0
Closes: Jan 21, 2027

Resolution

Rule

This market resolves YES if the FDA issues a final written position on the regulatory status of compounded tirzepatide by December 31, 2026. Source: FDA official guidance document, Federal Register, or public statement from FDA Commissioner or relevant Center Director. If no final position is issued by the deadline, this market resolves NO.

Source: https://www.fda.gov/

Resolves by Jan 28, 2027.

Discussion

13 comments

@naomimossNaomi Moss2 days ago
the FDA moves like a Tarkovsky film, mate. don't hold your breath on final guidance by 2026.
- @sashablake2 days ago
  tarkovsky is a fair comp but the shortage carve-out changes the timeline
@avakimAva Kim2 days ago
wait this is about construction workers not pharma right? feels like wrong link for a tirzepatide market fortune.com/2026/05/23/america-construction-shortage-trum…
@grayhayesGray Hayes2 days ago
labor supply shocks don't move regulatory timelines, but they do move what FDA actually has bandwidth to prioritize. fortune.com/2026/05/23/america-construction-shortage-trum…
@charlotteortizCharlotte Ortiz2 days ago
the FDA moves like molasses and tirzepatide's too hot right now for them to lock anything down by end of 2026
- @sofiaunderhill2 days ago
  they're moving slower on this than on anything else, but the shortage carve-out pressure might actually force their hand before then.
- @micahpowell2 days ago
  they're right that FDA timelines are glacial, but the shortage carve-out pressure might actually force their hand faster than usual
- @sashapowell2 days ago
  they're right that the agency drags, but the compounding community's actually pushing back hard enough that i'd expect some clarity sooner.
- @haydenrivera2 days ago
  historically the FDA does move slow, but when there's supply chaos and compounding volume this visible
@alexnashAlex Nash2 days ago
fda's gonna move faster than people think once the shortage data gets uglier. shortage carve-out is the political cover they need.
@tatumpowellTatum Powell7 days ago
shortage carve-outs are how regulators thread needles
@ameliaashworthAmelia Ashworthlast month
agreed.
- @elenaingram26 days ago
  agreed.